or
forgot password
  • cancer clinical trials in tampa, FL

  • A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Stage IV Melanoma
    BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Colorectal Cancer
    CAFE Study - Cancer Patient Fracture Evaluation
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Cancer, Spinal Fractures
    The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Carcinoma, Non-Small-Cell Lung
    Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Multiple Myeloma
    A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Rectal Neoplasms
    Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Colorectal Cancer
    Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Esophageal Cancer, Gastric Cancer
    Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Esophageal Adenocarcinomas, Adenocarcinomas of the Gastroesophageal Junction
    Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
    James A. Haley Veterans Administration Hospital
    Tampa, Florida 33612
    Colorectal Cancer
    Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Lung Cancer
    Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC
    H. Lee Moffitt Cancer Center & Research Insitute
    Tampa, Florida 33612
    Lung Cancer
    XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
    Moffitt Cancer Center and Research
    Tampa, Florida 33612
    Brain Edema, Brain Tumor
    Safety and Efficacy of RK0202 in Oral Mucositis
    H Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Mouth Diseases, Mouth Ulcers, Oral Mucositis, Head and Neck Cancer
    Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Non-Small Cell Lung Cancer
    Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
    James A. Haley Veterans Hospital

    Trial Locations
    James A. Haley Veterans Hospital
    Tampa Children's Hospital at St. Joseph's Hospital
    Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Myelofibrosis
    Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Dermatofibrosarcoma Protuberans
    TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Multiple Myeloma
    Study of Recombinant Human Thrombin for Bleeding During Surgery
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Surgical Hemostasis
    Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Neoplams, Advanced
    Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Leukemia, Lymphocytic, Acute, Leukemia, Nonlymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
    H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
    Tampa, Florida 33612
    Brain and Central Nervous System Tumors, Thromboembolism
    Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
    Tampa, Florida 33612
    Brain and Central Nervous System Tumors
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Xelero Medical Research/Giselle Ghurani
    Tampa, Florida 33607
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    Hematology Oncology Specialists
    Tampa, Florida 33607
    Diffuse Large-Cell Lymphoma
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    Saint Joseph Children's Hospital of Tampa
    Tampa, Florida 33607
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    Hillsborough County Health Dept.
    Tampa, Florida
    HIV Infections
    Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Leiomyosarcoma, Uterine Neoplasm
    A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
    H Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Myelodysplastic Syndrome
    A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
    H. Lee Moffitt Cancer & Research Institute
    Tampa, Florida 33612
    Hodgkin's Disease
    Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
    University of South Florida
    Tampa, Florida 33612
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
    Vaccine Treatment for Advanced Malignant Melanoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Malignant Melanoma
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
    Tampa, Florida 33612
    Brain and Central Nervous System Tumors
    Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
    Tampa, Florida 33612
    Lung Cancer
    Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Multiple Myeloma, Plasma Cell Leukemia
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    St. Joseph's Cancer Institute at St. Joseph's Hospital
    Tampa, Florida 33607
    Neuroblastoma
    Dendritic Cell Vaccination During Lymphoid Reconstruction
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Intraocular Melanoma, Melanoma (Skin)
    Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Malignant Melanoma
    A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes
    Lee Moffitt Cancer Center
    Tampa, Florida 33606
    Leukemia, Myelodysplastic Syndromes
    Response to Tipifarnib in Individuals With Large Granular Lymphocyte Leukemia
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Leukemia, Lymphocytic, Neutropenia, Anemia
    Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
    Axiom Clinical Research of Florida, 2919 Swann Avenue, Suite 401

    Trial Locations
    Axiom Clinical Research of Florida, 2919 Swann Avenue, Suite 401
    University of South Florida, Department of Neurology
    Multiple Sclerosis
    Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Non-small Cell Lung Cancer
    Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
    H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
    Tampa, Florida 33612
    Leukemia, Myelodysplastic Syndromes
    Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia
    Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Malignant Melanoma
    GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
    Tampa General Hospital Usf Digestive Disorders Centre
    Tampa, Florida 33606
    Advanced Unresectable Pancreatic Cancer
    Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Mucositis, Graft-versus-host Disease
    Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Astrocytoma, Glioma, Oligodendroglioma
    A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Multiple Myeloma
    Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Myeloma, Lymphoma
    Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
    H. Lee Moffit Cancer Center & Research Institute
    Tampa, Florida 33612
    Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor, Pancreatic Neoplasms
    Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer
    H. Lee Moffitt Cancer Center & Research Insitute
    Tampa, Florida 33612
    Cancer
    Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Acute Myeloid Leukemia (AML)
    Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Glioblastoma, Gliosarcoma
    Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Breast Cancer
    External Beam Radiation With Intratumoral Injection Of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Soft Tissue Sarcoma
    Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Precancerous Condition, Stage I Non-small Cell Lung Cancer, Tobacco Use Disorder
    Patient Navigator Project
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Breast Cancer, Colon Cancer